COLINZPharmaceuticals
Colinz Laboratories Ltd — Cash Flow Statement
₹44.50
+0.00%
Colinz Laboratories Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -1.72 Cr | 1.03 Cr | 0.40 Cr | 0.43 Cr | — |
| Capital Expenditure | -0.26 Cr | — | — | -0.04 Cr | -0.16 Cr |
| End Cash Position | 5.55 Cr | 7.00 Cr | 5.73 Cr | 5.21 Cr | — |
| Beginning Cash Position | 7.00 Cr | 5.73 Cr | 5.21 Cr | 4.68 Cr | — |
| Changes In Cash | -1.45 Cr | 1.27 Cr | 0.52 Cr | 0.52 Cr | — |
| Financing Cash Flow | 0.24 Cr | 0.23 Cr | 0.11 Cr | 0.09 Cr | — |
| Net Other Financing Charges | 0.28 Cr | 0.27 Cr | 0.16 Cr | 0.17 Cr | — |
| Interest Paid Cff | -0.04 Cr | -0.04 Cr | -0.05 Cr | -0.08 Cr | — |
| Investing Cash Flow | -0.23 Cr | 69000.00 | 87000.00 | -0.03 Cr | — |
| Dividends Received Cfi | 84000.00 | 69000.00 | 87000.00 | 50000.00 | — |
| Net Investment Purchase And Sale | 0.02 Cr | 0.00 | 0.00 | 0.00 | — |
| Sale Of Investment | 0.02 Cr | 0.00 | — | — | — |
| Purchase Of Investment | 0.00 | 0.00 | — | — | — |
| Net PPE Purchase And Sale | -0.26 Cr | 0.00 | 0.00 | -0.04 Cr | — |
| Purchase Of PPE | -0.26 Cr | 0.00 | 0.00 | -0.04 Cr | — |
| Operating Cash Flow | -1.45 Cr | 1.03 Cr | 0.40 Cr | 0.47 Cr | — |
| Taxes Refund Paid | -0.21 Cr | -0.18 Cr | -0.16 Cr | -0.15 Cr | — |
| Change In Working Capital | -1.75 Cr | 0.67 Cr | -0.07 Cr | 0.03 Cr | — |
| Change In Other Current Liabilities | 42000.00 | 0.35 Cr | -0.28 Cr | -0.49 Cr | — |
| Change In Other Current Assets | -2.00 Cr | 46000.00 | 60000.00 | 0.18 Cr | — |
| Change In Payable | -0.05 Cr | -0.06 Cr | 0.18 Cr | -0.07 Cr | — |
| Change In Inventory | 0.07 Cr | 0.09 Cr | -0.01 Cr | 0.32 Cr | — |
| Change In Receivables | 0.20 Cr | 0.27 Cr | 0.07 Cr | 0.09 Cr | — |
| Other Non Cash Items | -0.24 Cr | -0.23 Cr | -0.11 Cr | -0.09 Cr | — |
| Depreciation And Amortization | 0.13 Cr | 0.13 Cr | 0.13 Cr | 0.20 Cr | — |
| Depreciation | 0.13 Cr | 0.13 Cr | 0.13 Cr | 0.20 Cr | — |
| Gain Loss On Investment Securities | -84000.00 | -69000.00 | -87000.00 | -50000.00 | — |
| Net Income From Continuing Operations | 0.62 Cr | 0.65 Cr | 0.60 Cr | 0.48 Cr | — |
| Net Other Investing Changes | — | 69000.00 | — | — | 14000.00 |
| Gain Loss On Sale Of PPE | — | 0.00 | 0.02 Cr | 0.00 | — |
| Other Cash Adjustment Outside Changein Cash | — | — | — | — | -0.01 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Colinz Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.